RE: Morning All28 Jul 2019 12:53
Morning C7
Somebody at the FDA has obviously blocked the trial or the approval if you prefer, due to the reaction of the electroploration on either SCIB 1 or more likely, what happens to the Checkpoint Inhibitor, which I'm presuming will already have been administered to the patient.
Seems an awful long time has passed while new data has had to be submitted and still no comment from the FDA.
Maybe the FDA are now awaiting the first UK trial data.
Either pure bureaucracy with an intern in charge or lumped on somebodys desk with a 1,000 other applications.
Chester.